A middle-aged woman sustained serious heart valve injury (i.e.
primary pulmonary hypertension) from taking a prescribed diet drug
Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury
firm who settled the case.
$2.5 Million Settlement
A wife and mother of two children died of a cerebral hemorrhage
after taking an over the counter diet drug diet drug containing
Ephedra. The deceased’s husband contacted our firm for help.
Our firm maintained joint responsibility with an experienced product liability attorney who settled
the case.
$900,000 Settlement
We were co-counsel in a case involving a dietary supplement with
PPA. The client suffered a stroke and had a brain bleed that required
two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney
who settled the case.
$ 750,000 Settlement
A teenager committed suicide after taking an anti-depressant drug
for several weeks. The young boy’s life was cut short just
one week before his birthday. Our firm maintained joint responsibility with an experienced product liability
attorney who settled the case.
$1.25 Million Settlement
Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement
When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements
Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total
Settlements
A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement
Ketek is an antibiotic used for the treatment of serious and drug resistant bacterial infections. Ketek was approved by the U.S. Food and Drug Administration (FDA) in April 2004 and is manufactured by Sanofi-Aventis.
Since its approval in 2004, Ketek has proven controversial. In June 2006, the risk of liver damage was added to the label and in February 2007 the approved uses were reduced. The drug has undergone two FDA reviews and a senate investigation. Ketek is now approved only for community-acquired pneumonia in patients 18 years of age and older. Previously, the drug was also approved for the treatment of pneumonia, chronic bronchitis and sinusitis.
The FDA made the decision to limit the uses of Ketek because the benefits do not out weigh the risks. The label change in February 2007 also strengthened warnings for the risk of liver damage, loss of consciousness and visual disturbances. The warning includes that no one with myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily) should take Ketek.
Prior to the approval of Ketek, the FDA was aware of potential liver problems but believed they were similar to other marketed antibiotics. Yet in January 2006, Annals of Internal Medicine published an article reporting on three patients with serious liver toxicity. One patient recovered, one patient had to undergo a liver transplant and the third patient died as a result. When the livers of the latter two patients were examined in the laboratory, massive tissue death was found.
All three patients were reported as not taking any other medications. The patients in the report were also only on the drug for a few days after symptoms of acute hepatitis occurred and all had jaundice and abnormal results on liver function tests. All three cases were reported to the FDA.
PLEASE SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING THE USE OF KETEK OR ANY OTHER PRESCRIPTION DRUGS.
If you or a loved one has been injured due to the use of Ketek, you need a Ketek attorney familiar with new developments in the investigation of Ketek to help you make important personal and legal decisions, and if needed to file a lawsuit. Contact us now to get the help you deserve.
Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.
Questions and Answers on Ketek (telithromycin) from the FDA Website